Insider Trading28 Sept 2026, 06:10 pm
Astec Lifesciences Closes Trading Window for Q2 FY27 Results
AI Summary
Astec Lifesciences Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter and half-year ending September 30, 2026. All officers, designated employees, including directors and auditors, are prohibited from trading in the company's equity shares during this period.
Key Highlights
- Trading window closed from October 1, 2026.
- Closure is for Q2 FY27 and half-year ending September 30, 2026.
- Prohibits trading by directors, officers, and designated employees.
- Effective until 48 hours post financial results declaration.
- Adheres to SEBI's Prohibition of Insider Trading Regulations.
Price Impact
More from ASTEC